Myostatin, Activin Or Activin Receptor Antagonists For Use In Treating Obesity And Related Conditions - EP3558361

The patent EP3558361 was granted to Novartis on Aug 20, 2025. The application was originally filed on Dec 20, 2017. The patent is currently recorded with a legal status of "Granted".

EP3558361

NOVARTIS
Filing Date
Dec 20, 2017
Status
Granted
Grant Date
Aug 20, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Get instant alerts for new documents